Johnson & Johnson, Eli Lilly Pause COVID-19 Drug Trials

The phase 3 trial of Johnson & Johnson

The move by Eli Lilly came less than 24 hours after Johnson & Johnson paused further dosing in all of its COVID-19 vaccine candidate clinical trials while it investigated a volunteer’s illness.

(Image credit: Cheryl Gerber/AP)

You May Also Like